MK8591A052 Phase III Trial of DOR and ISL
MK-8591A-052: Phase III Trial of Switch From BIC/FTC/TAF to DOR/ISL in People Living With Virologically Suppressed HIV

Released: March 12, 2025

Expiration: September 11, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: March 12, 2025

Expiration: September 11, 2025